TELA Bio (TELA) Current Leases (2022 - 2026)
TELA Bio's (TELA) quarterly Current Leases came in at $527000.0 in Q1 2026, down 0.94% year-on-year from $532000.0 in Q1 2025, and up 0.57% quarter-over-quarter from $524000.0 in Q4 2025.
TELA Bio (TELA) Current Leases (2022 - 2026) Analysis & Trends
TELA Bio's Current Leases history runs 5 years deep, the most recent figure standing at $527000.0 for Q1 2026.
- On a quarterly basis, Current Leases fell 0.94% year-over-year to $527000.0 in Q1 2026; TTM through Mar 2026 was $527000.0, a 0.94% decrease from a year earlier, with the FY2025 full-year figure at $524000.0, up 4.8% from the prior year.
- Current Leases climbed to $527000.0 in Q1 2026 per TELA's latest filing, from $524000.0 in the prior quarter.
- Across five years, Current Leases topped out at $571000.0 in Q2 2024 and bottomed at $300000.0 in Q3 2022.
- The 5-year median for Current Leases is $518000.0 (2025), against an average of $455176.5.
- Biggest YoY gain for Current Leases was 66.47% in 2024; the steepest drop was 11.5% in 2024.
- Year by year, Current Leases stood at $340000.0 in 2022, then jumped by 66.18% to $565000.0 in 2023, then dropped by 11.5% to $500000.0 in 2024, then grew by 4.8% to $524000.0 in 2025, then advanced by 0.57% to $527000.0 in 2026.
- Per Business Quant, the three latest TELA Current Leases figures stand at $527000.0 (Q1 2026), $524000.0 (Q4 2025), and $521000.0 (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | - |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | - |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | - |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 24.30 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 20.50 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | - |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | - |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | TELA Bio | 40.65 Mn | 1.11 Mn | 12.52 Mn | 527,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 527,000.00 |
| Dec 31, 2025 | 524,000.00 |
| Sep 30, 2025 | 521,000.00 |
| Jun 30, 2025 | 518,000.00 |
| Mar 31, 2025 | 532,000.00 |
| Dec 31, 2024 | 500,000.00 |
| Sep 30, 2024 | 559,000.00 |
| Jun 30, 2024 | 571,000.00 |
| Mar 31, 2024 | 568,000.00 |
| Dec 31, 2023 | 565,000.00 |
| Sep 30, 2023 | 345,000.00 |
| Jun 30, 2023 | 343,000.00 |
| Mar 31, 2023 | 342,000.00 |
| Dec 31, 2022 | 340,000.00 |
| Sep 30, 2022 | 300,000.00 |
| Jun 30, 2022 | 336,000.00 |
| Mar 31, 2022 | 347,000.00 |